Is this email not displaying correctly?
View it in your browser.
Newswise - News for Journalists

Newswise Special Wire
Tuesday, May 17, 2016

Public edition |

Newswise Cancer Research Wire for 17-May-2016

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Research Indicates That Many Are Using Sunscreen Incorrectly

According to new research, many people are still puzzled by the wide range of SPF numbers on product labels, and some may not be using sunscreen properly, which could increase their skin cancer risk.

Journal of the American Academy of Dermatology

– American Academy of Dermatology

New Ultrasound Method Increases Awareness About Cancer Cells

Researchers at Lund University in Sweden and the Massachusetts Institute of Technology in the United States have developed a method to analyse and separate cells from the blood. Ultimately, the method, which goes under the name iso-acoustic focusing, can become significant to measure the efficiency of cancer treatments for individuals.

 • Image(s) embedded • 

Nature Communications May 2016

– Lund University

Top Stories 5-17-2016

click to view today's top stories

– Newswise Trends

Blocking Known Cancer Driver Unexpectedly Reveals a New Tumor-Promoting Pathway

While investigating a potential therapeutic target for the ERK1 and 2 pathway, a widely expressed signaling molecule known to drive cancer growth in one third of patients with colorectal cancer, University of California San Diego School of Medicine researchers found that an alternative pathway immediately emerges when ERK1/2 is halted, thus allowing tumor cell proliferation to continue.

 • Image(s) embedded • 

Nature Communications; AI095623, DK035108, AI043477, CA160398

– University of California, San Diego Health Sciences

New Cancer Immunotherapy Approach Combines Tumor Fighting Power with Fewer Side Effects, Study Shows

Basic research into the dual nature of certain immune system cells has set the stage for a new approach to cancer immunotherapy that avoids some of the shortcomings associated with other methods, scientists at Dana-Farber Cancer Institute report in a new study.

 • Image(s) embedded •  (Embargo expired on 16-May-2016 at 15:00 ET)

– Dana-Farber Cancer Institute

Promise of Nearly a Year of Life on Targeted Drug Not Reality for All Liver Cancer Patients, Study Finds

In the journal The Oncologist, researchers report that the median survival for a group of Medicare patients on the drug sorafenib was three months, which was significantly lower than the median survival of nearly 11 months for patients treated with the drug during a phase III clinical trial.

 • Image(s) embedded •  (Embargo expired on 16-May-2016 at 12:00 ET)

The Oncologist, May-2016

– University of North Carolina Health Care System

Stage IIIA Non-Small Cell Lung Cancer Survival Rates Improved When Care Includes Four Specific Quality Measures

Analysis of data from the National Cancer Data Base (NCDB) demonstrates that the survival rates of patients with Stage IIIA NSCLC who underwent surgery increased more than three-fold for those who received four quality measures as part of their care. The study, presented by Pamela Samson MD, MPHS, of Washington University in St. Louis at the 96th AATS Annual Meeting, also shows a wide variability in compliance with quality measures, with only 12.8% of almost 8,000 eligible patients having received all four interventions. The study highlights the importance of implementing these recommended steps into actual practice.

(Embargo expired on 16-May-2016 at 10:25 ET)

96th American Association for Thoracic Surgery Annual Meeting

– American Association for Thoracic Surgery (AATS)

Top Stories 5-16-2016

click to view today's top stories

– Newswise Trends

Cancer Risk Perception Could Lead to Adverse Health Outcomes Among Women

According to recent studies, the U.S. has a disadvantage in women’s life expectancy compared to peer countries despite high rates of health screenings such as mammography and popular national awareness campaigns. Recently, researchers at the University of Missouri examined the perceptions of risk among females and found that minority and less educated women believe that breast cancer, rather than heart disease, is the more common killer. Based on these findings, they recommend that health care providers should incorporate healthier lifestyle strategies for heart disease with messages for improved breast health to greater impact disease outcomes.

URC 11-009

– University of Missouri Health

Big Data Can Save Lives, Says Leading Queen’s University Cancer Expert

The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen’s University Belfast.

 • Image(s) embedded • 

Nature Medicine

– Queen's University Belfast

Researchers Discover Blood Marker That Better Defines Who Will Respond to Drug Used in Metastatic Colorectal Cancer

Cancer researchers have identified a marker that shows up in a blood test that determines which patients with colorectal cancer that has spread would benefit from receiving the drug cetuximab.

 • Video / Image(s) embedded •  (Embargo expired on 13-May-2016 at 00:05 ET)

– University Health Network (UHN)

Top Stories 5-13-2016

click to see today's top stories

– Newswise Trends

Genetic Biomarker May Predict Nerve Pain Side Effects Associated with Prostate Cancer Treatment, Moffitt Researchers Say

Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, but its use can be limited by significant side effects. Researchers from Moffitt Cancer Center report prostate cancer patients who have a variation in the VAC14 gene are more susceptible to a side effect called peripheral neuropathy when treated with the taxane docetaxel.

U01GM61390; U01GM61393; P30NR014129

– Moffitt Cancer Center

Gene Regulatory Mutation Linked to Rare Childhood Cancer

A single defect in a gene that codes for a histone — a "spool" that wraps idle DNA — is linked to pediatric cancers in a study published today in the journal Science. "Unlike most cancers that require multiple hits, we found that this particular mutation can form a tumor all by itself," says Peter W. Lewis, an assistant professor of biomolecular chemistry in the School of Medicine and Public Health at the University of Wisconsin-Madison.

 • Image(s) embedded •  (Embargo expired on 12-May-2016 at 14:00 ET)

Science May 12 2016

– University of Wisconsin-Madison

Cancer Patients with Depression ‘Struggle to Get Their Lives Back After Treatment’

People with depression are significantly less likely to recover well after treatment for colorectal cancer compared to those without depression, according to new research by Macmillan Cancer Support and the University of Southampton.

(Embargo expired on 12-May-2016 at 19:00 ET)


– University of Southampton

Exercise May Reduce the Risk of Cervical Cancer, Breast Cancer Screening Accuracy, Genome Analysis Leads to Clues About Rare Cancer, and more in the Cancer News Source

Exercise May Reduce the Risk of Cervical Cancer, Breast Cancer Screening Accuracy, Genome Analysis Leads to Clues About Rare Cancer, and more in the Cancer News Source

– Newswise

Breast Cancer Drug Found to Reduce Seizures

A class of drug that inhibits estrogen production and is used to treat breast cancer has been found to quickly and effectively suppress dangerous brain seizures, according to a new Northwestern University study. The effect was profound, say the neuroscientists, who conducted the study in an animal model of status epilepticus, a condition characterized by a prolonged episode of seizure activity. The results show that clinically available drugs could be effective therapies for suppressing seizures in humans.


– Northwestern University

Boston Cancer Support to Receive ASTRO Survivor Circle Grant

The American Society for Radiation Oncology (ASTRO) has selected a Boston-based organization, Boston Cancer Support, to receive one of two 2016 ASTRO Survivor Circle grants.

– American Society for Radiation Oncology (ASTRO)

Beware of Black Salve

According to new research published in the May issue of the Journal of the American Academy of Dermatology, the vast majority of patients who use the home remedy black salve do so without talking to a dermatologist first — and as a result, many are unaware of how harmful it can be.

Journal of the American Academy of Dermatology

– American Academy of Dermatology

Top Stories 5-11-2016

click to see today's top stories

– Newswise Trends

Quality of Life Meets Cure for Prostate Cancer Treatment

A new paper looks at how MRI and a clear understanding of the functional anatomy around the prostate can allow radiation oncologists to plan a course of treatment for patients with prostate cancer that spares these critical structures.

 • Video / Image(s) embedded • 

Lancet Oncology

– University of Michigan Health System

Exercise May Reduce the Risk of Cervical Cancer

Even 30 minutes of exercise per week has the potential to significantly reduce a woman’s risk of developing cervical cancer, according to a study from scientists at Roswell Park Cancer Institute (RPCI). The case-control study was recently published in the Journal of Lower Genital Tract Disease.

Journal of Lower Genital Tract Disease; T32CA108456 and P30CA016056

– Roswell Park Cancer Institute


State Helping New Mexico Women Get 3D Mammograms

A $250,000 state appropriation is helping eligible New Mexico women to get three-dimensional mammography through The University of New Mexico Hospital and the UNM Comprehensive Cancer Center.

– University of New Mexico Comprehensive Cancer Center

A Persistent Pioneer in Breast Cancer Research

Dr. Carol Fabian honored for her work changing the odds for women with breast cancer and those at increased risk for the disease.

 • Image(s) embedded • 

– University of Kansas Cancer Center

Harris Health Named C Cancer Gold Standard™ Employer for Fourth Straight Year

Harris Health System has again earned the CEO Cancer Gold Standard by the CEO Roundtable on Cancer for its efforts to reduce the risk of cancer for its employees and covered family members. The health system is one of five other hospital systems in Texas to receive the coveted recognition.

 • Image(s) embedded • 

– Harris Health System

Cancer Research Institute Hosts Answer to Cancer Cycling Event

One-day, multi-distance ride through the Lower Hudson Valley’s breathtaking landscape to raise funds for the nonprofit Cancer Research Institute and increase awareness of the potential of immunotherapy to cure all cancers.

 • Video / Image(s) embedded • 

– Cancer Research Institute

Scotiabank Named Title Sponsor for the Princess Margaret Cancer Foundation’s Annual Road Hockey to Conquer Cancer Tournament

The Princess Margaret Cancer Foundation is thrilled to announce Scotiabank as the new title sponsor for the Scotiabank Road Hockey to Conquer Cancer annual tournament for the next five years.

 • Image(s) embedded • 

– University Health Network (UHN)

Cancer Survival Rates at Virginia Mason Rank Among Best in Nation, Statistics Show

Survival rates for patients treated for a variety of cancers at Virginia Mason Medical Center in Seattle are among the best in the United States, recent national data shows.

 • Image(s) embedded • 

– Virginia Mason Medical Center

Memorial Sloan Kettering Expands into Northern New Jersey

Memorial Sloan Kettering Cancer Center (MSK) will further enhance its ability to offer top cancer care to even more patients with the establishment of a freestanding, state-of-the-art outpatient treatment center in Bergen County, New Jersey. Residents from communities across northern New Jersey and southern New York State will have easier access to MSK’s unique expertise when MSK Bergen becomes fully operational in winter 2017.

– Memorial Sloan Kettering Cancer Center

GW Cancer Center Receives $100K from Susan G. Komen to Reduce Breast Cancer Disparities in D.C’s Lesbian, Bisexual, and Transgender Communities

The GW Cancer Center received nearly $100,000 to reduce cancer disparities in Washington, D.C.’s lesbian, bisexual, and transgender communities from Susan G. Komen.

– George Washington University

Expert Pitch

#Exercise and #Cancer Risk: @Fredhutch Expert Can Comment on Study in Today's JAMA Internal Medicine

 • Image(s) embedded • 

– Fred Hutchinson Cancer Research Center

subscribe/unsubscribe :: edit my preferences
© 2016 Newswise, Inc. All Rights Reserved. | 215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417 | Contact Us